FGF10 and gastric adenocarcinoma: FGF10 amplification has also been detected in 3% of gastric cancers (Ooi et al., 2015) and immunohistochemical analysis of 178 gastric adenocarcinoma samples revealed that FGF10 levels are correlated with poor prognosis (Sun et al., 2015).